The pilot study of a new “vaccine” for type 1 has yielded disappointing results so far, with children who received the vaccine no less likely to develop type 1 than children in the control group, researchers announced. However, researchers plan to test additional combinations of the formulation, and have not ruled out hope. Read more
A new study from Australia reports that the diabetes drug canagliflozen may have benefits beyond lowering blood sugar in patients with type 2 diabetes. It also may lower the risk of cardiovascular disease (CVD) and kidney disease significantly. Read more
A new clinical trial has found people with diabetes who received health-related text messages every day for six months showed improvement in their blood glucose levels. The improvement was comparable to that achieved with some diabetes drugs. The trial focused on low-income Hispanics with type 2, and assessed texting as a low-cost intervention that could […]
High alcohol consumption and binge drinking starting in the teens is associated with raising women’s blood glucose levels, putting them at greater risk for developing type 2 diabetes, according to a new study. Men are not similarly affected. Read more
Nevada is considering legislation that would track the profits pharmaceutical companies make on sales of insulin. It’s a move hailed by many patients with diabetes – yet patient advocacy groups have had little to say on the subject. Read more
Being diagnosed with type 1 diabetes at the age of 15 didn’t stop Romain Gioux from pursuing his dream. Now he competes professionally as part of Team Novo Nordisk, a group of elite athletes who haven’t let their diabetes diagnoses slow them down.
Cardiovascular disease is the leading cause of death in people with type 1 diabetes. A new study suggests that just one additional injection of insulin three hours after eating could provide protection. Read more
A new study found the diabetes drug liraglutide performed better than placebo in reducing the risk that patients with prediabetes would progress to type 2 diabetes, when combined with a program of diet, exercise and weight loss. Read more
Most exercise programs run a disclaimer: check with your HCP before starting this program! But do you really need to? That depends on your overall health and the type of exercise program. For walking or other simple exercises, the American Diabetes Association doesn’t recommend you need to wait to talk to your doctor before starting. […]
Biomedical engineers have created a technology that might mean current daily or weekly insulin shots for type 2 diabetics might one day be administered just once or twice a month. In primate tests, the drugs last for weeks rather than days. Read more
People with type 2 diabetes are often at increased risk of cardiovascular problems. Researchers have announced that measuring a blood marker called copeptin can successfully predict which patients are at risk, and may be used to prevent heart disease in patients with diabetes. Read more
JDRF, formerly known as the Juvenile Diabetes Research Foundation, has launched a new campaign aimed at adovating for better insurance coverage for Americans with type 1 diabetes. The campaign, called Coverage2Control, is aimed at the many people with type 1 who are facing healthcare uncertainties and concerns about treatment choices, particularly with the current controversy […]
Researchers have obtained the first cryo-electron microscopy images of a key cellular receptor for diabetes in action. These images provide new information about how G protein-coupled receptors (GPCRs) work. GPCRs conduct molecular messages for most functions in the human body. Read more
ViaCyte has obtained $10 million in financing to fund the clinical development of its stem cell-derived treatment for type 1 diabetes. The treatment uses stem cell-derived pancreatic cells in an implantable device. The cells are designed to mature into human pancreatic cells, including insulin-secreting beta cells. Read more
The UK National Institute of Health and Care Excellence (NICE) has revised its type 2 diabetes guidelines to give more prominence to sodium-glucose cotransporter 2 (SGLT-2) inhibitor drugs as a treatment option. While a warning about the association of these drugs with diabetic ketoacidosis (DKA) remains, the guidelines offer stronger support of these drugs as treatments. Currently […]
Major pharma company Roche has made changes to its blood glucose monitoring system and introduced a new discounting offer, which is says could save uninsured diabetes patients thousands of dollars per year. This may be aimed to address the scrutiny drug companies are receiving over pricing, including the cost of insulin. Read more
A study in Germany found those with lower levels of formal education scored higher in most risk factors for diabetes, including obesity, lack of exercise, and poor diet. Read more
Death rates for black children with diabetes are more than twice as high as those for white children with the disease, and more than three times higher than those for Hispanic children, according to data released in in Morbidity and Mortality Weekly Report on May 19, 2017. The researchers suggest differences in access to healthcare […]
Gene therapy, in which lab-designed genes are inserted into patients to treat their health conditions, often is focused on type 1 diabetes. However, researchers are now reporting an experiment in using gene therapy to treat type 2 diabetes is showing some success. Read more
The FDA has issued a new warning for the type 2 diabetes medicine canagliflozin (offered under the brand names Invokana, Invokamet, and Invokamet XR). Two large clinical trials have indicated the drug carries an increased risk of leg and foot amputations. The FDA advises patients taking canagliflozin to immediately notify their doctor if they experience new pain […]